Edition:
United States

Hikma Pharmaceuticals PLC (HIK.L)

HIK.L on London Stock Exchange

1,850.50GBp
11:56am EDT
Change (% chg)

-4.00 (-0.22%)
Prev Close
1,854.50
Open
1,884.00
Day's High
1,905.00
Day's Low
1,846.50
Volume
331,794
Avg. Vol
580,501
52-wk High
2,033.00
52-wk Low
814.20

Chart for

About

Hikma Pharmaceuticals Plc is a pharmaceutical company. The Company is focused on developing, manufacturing and marketing a range of both branded and non-branded generic and in-licensed products. The Company's segments include Branded, Injectables, Generics and Others. It sells branded generics and in-licensed patented products... (more)

Overall

Beta: 0.98
Market Cap(Mil.): £4,541.93
Shares Outstanding(Mil.): 241.42
Dividend: 9.40
Yield (%): --

Financials

  HIK.L Industry Sector
P/E (TTM): -- 30.48 32.69
EPS (TTM): -2.73 -- --
ROI: -27.71 13.04 12.72
ROE: -43.08 14.99 14.85

Hikma raising injectable opioids output to help ease shortage at U.S. hospitals

LONDON London-listed pharmaceutical group Hikma said on Wednesday it was increasing its supply of hydromorphone to U.S. hospitals to help ease a shortage of injectable opioids used to treat patients.

Jul 18 2018

Hikma raising injectable opioids output to help ease shortage at U.S. hospitals

LONDON, July 18 London-listed pharmaceutical group Hikma said on Wednesday it was increasing its supply of hydromorphone to U.S. hospitals to help ease a shortage of injectable opioids used to treat patients.

Jul 18 2018

Earnings vs. Estimates